Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBupa Fin. 35 Regulatory News (82GS)

Share Price Information for Bupa Fin. 35 (82GS)

Share Price is delayed by 15 minutes
Get Live Data
84.44    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
82GS Live PriceLast checked at - London Stock Exchange

Intraday Bupa Fin. 35 Share Chart

Moody's Affirms Bupa's Rating

20 May 2026 13:17

RNS Number : 1371F
BUPA Finance PLC
20 May 2026
 

RNS

 

LEI Number: ZIMCVQHUFZ8GVHENP290

 

20 May 2026

 

Moody's Ratings affirms Bupa's A1 Insurance Financial Strength Rating; outlook stable

 

Moody's Ratings ('Moody's') today has affirmed the A1 Insurance Financial Strength Ratings of Bupa Insurance Ltd, the main UK private medical insurance business of the wider Bupa Group ('Bupa' or 'group'), and group subsidiary Bupa Global Designated Activity Company.

 

Moody's have also affirmed the A3 backed senior unsecured, Baa1(hyb) subordinated and Baa3(hyb) preferred stock non-cumulative debt ratings of Bupa Finance Plc.

 

The outlook on all entities remains stable.

 

See the full announcement from Moody's here.

 

 

Enquiries

 

Media: Duncan West (Corporate Affairs): duncan.west@bupa.com

Investors: Gareth Evans (Group Treasury): ir@bupa.com

 

About Bupa

 

Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.

 

For more information, visit www.bupa.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLBLFLQELFBBX
Date   Source Headline
20th May 20261:17 pmRNSMoody's Affirms Bupa's Rating
5th Mar 20267:00 amRNSAnnual Financial Report
20th Nov 20254:33 pmRNSDebt Issuance & Tender Offer - Final Announcement
18th Nov 20251:35 pmRNSTender Offer - Final Results
18th Nov 20259:25 amRNSTender Offer - Indicative Results
14th Nov 20254:34 pmRNSIssuance - Publication of Admission Particulars
12th Nov 202510:19 amRNSTender Offer - Maximum Acceptance Amount
10th Nov 20258:42 amRNSTender Offer
7th Aug 20257:00 amRNSHalf-year Report
6th Mar 20257:00 amRNSAnnual Financial Report
15th Oct 20246:00 pmRNSFitch Ratings upgrades Bupa Finance plc
1st Aug 20247:00 amRNSHalf-year Report
10th Jul 202412:06 pmRNSMoody’s affirms Bupa Insurance Limited’s Rating
7th Mar 20247:00 amRNS2023 Annual Report
10th Nov 20239:00 amRNSPost Stabilisation Notice
10th Oct 20234:17 pmRNSProspectus published re EUR 500m Notes due 2030
5th Oct 20235:35 pmRNSPricing of EUR 500 million Fixed Rate Notes 2030
3rd Aug 20237:04 amRNSBupa Finance Plc Announces 2023 Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.